Estatísticas para RT 1161 2019 - sorafenibe (tosilato de sorafenibe) para hepatocarcinoma - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| RT 1161 2019 - sorafenibe (tosilato de sorafenibe) para hepatocarcinoma - NATJUS TJMG | 20 |
Total visitas por mês
| views | |
|---|---|
| October 2025 | 0 |
| November 2025 | 2 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 2 |
Visitas Arquivos
| views | |
|---|---|
| RT 1661.pdf | 17 |